SRSF2 and chronic myelomonocytic leukemia: The most interesting contribution of this study was the finding of SRSF2 P95 hotspot mutations, found in 40–50% of patients suffering from CMML, which were retrospectively detected in both the skin and BM biopsies of the three patients.